Movetru, a Northern Ireland-based AI wearables startup, has raised €1.4 million (US1.9 million) in pre-seed funding.

The company specializes in movement analysis and injury prevention for athletes.

Founded by Naomi McGregor, Movetru offers a wearable device and AI-powered app that delivers real-time biomechanical insights.

The funding round was led by Two Magnolias, with participation from IAG Capital, HBAN, Angel Academe, AwakenAngels, and several angel investors with expertise in sports and biomechanics.

Movetru plans to use the funds to scale its operations and expand its commercial rollout.

The technology is currently used by various sports organizations across the UK and Ireland.

.source-ref{font-size:0.85em;color:#666;display:block;margin-top:1em;}a.ask-tia-citation-link:hover{color:#11628d !important;background:#e9f6f5 !important;border-color:#11628d !important;text-decoration:none !important;}@media only screen and (min-width:768px){a.ask-tia-citation-link{font-size:11px !important;}}

🔗 Source: Tech.eu

🧠 Food for thought

1️⃣ The evolution of sports medicine: from reactive treatment to proactive prevention

Movetru’s technology represents a significant shift in sports medicine that has been developing over decades.

Sports medicine has evolved from a purely biomedical model focusing on treatment after injury to a comprehensive biopsychosocial approach emphasizing prevention through multiple factors 1.

This transformation began in the 1990s with models like Van Mechelen’s Sequence of Prevention (1992), which outlined a four-step process: identifying the problem, understanding causes, implementing preventive measures, and assessing effectiveness 2.

Modern approaches now recognize that injury prevention requires continuous monitoring of biomechanical factors and movement patterns, which Movetru’s wearable technology delivers through real-time insights.

The shift toward prevention is financially significant too, as inadequate training and poor movement quality lead to substantial medical costs and lost playing time that could be avoided with early intervention technologies 3.

2️⃣ Democratizing advanced sports science for broader accessibility

Movetru’s funding success highlights a growing trend of making professional-grade sports science accessible beyond elite athletics.

Historically, comprehensive biomechanical analysis was largely confined to professional teams and research laboratories with expensive equipment, creating a significant gap in care for amateur athletes and those in rehabilitation 4.

Movetru’s approach of combining wearable technology with AI-powered smartphone apps allows coaches and athletes to access sophisticated movement data without specialized facilities 3.

This accessibility is particularly important for female athletes, who are significantly underrepresented in sports technology research despite being at higher risk for certain injuries like ACL tears—a specific focus area for Movetru’s technology 5.

The positive feedback from diverse organizations like the Belfast Giants ice hockey team demonstrates how this accessibility is already proving valuable across different sporting contexts and levels of competition.

3️⃣ Sports tech investment boom reflects maturing injury prevention market

The €1.4 million raised by Movetru fits into a broader explosion of investment in sports technology, with the sector seeing $2.5 billion in February 2025 alone following a record $3.9 billion in January 6.

This funding surge reflects growing investor recognition that preventive technologies addressing biomechanics and movement quality represent a significant market opportunity, with several funds now dedicated specifically to sports technology innovation 7.

The composition of Movetru’s investor group—including not just venture capital but also medical experts like Dr. Mark Batt and industry figures such as the former AFC Bournemouth chairman—demonstrates how sports tech is attracting cross-disciplinary investment interest.

Movetru’s focus on leveraging AI for performance optimization and injury prevention aligns with investor priorities in the sector 8.

The company’s emphasis on validated, evidence-based approaches through trials with 100 participants demonstrates the increasing maturity of the sports tech market, where investors now expect scientific rigor alongside innovative technology 3.

……